The World Health Organisation (WHO) has stopped hydroxychloroquine solidarity trials on Covid-19 patients, after it found that the drug is not beneficial in the treatment of the virus. The WHO said the drug does not decrease the mortality rate of the virus, hence its decision to finally stop tria
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp